Realta Life Sciences, Inc.
Clinical trials sponsored by Realta Life Sciences, Inc., explained in plain language.
-
New drug hope for brain-damaged newborns in landmark trial
Disease control Recruiting nowThis study tests a new medicine called RLS-0071 in 70 newborns who have brain injury from not getting enough oxygen at birth. The babies also receive standard cooling therapy. The goal is to see if the drug is safe and can reduce brain damage and long-term problems like disabilit…
Phase: PHASE2 • Sponsor: ReAlta Life Sciences, Inc. • Aim: Disease control
Last updated May 17, 2026 23:49 UTC
-
New hope for bone marrow transplant patients with Life-Threatening immune attack
Disease control Recruiting nowThis study tests a new drug called RLS-0071 in 66 hospitalized patients who have a serious complication after a stem cell transplant, known as graft-versus-host disease (GVHD), that is not responding to steroids. The goal is to find the best dose and see if the drug is safe and c…
Phase: PHASE2 • Sponsor: ReAlta Life Sciences, Inc. • Aim: Disease control
Last updated May 06, 2026 16:01 UTC